PDS Biotechnology Corporation
- PDSB
- NASDAQ
- Biotechnology
- Immuno-Oncology
- Cancer Immunotherapy
- Clinical-Stage Biotech
$1.13
Today −13.08%Quote Oct 16, 2026, 08:00 PM UTC
+34.17%over the last month
Max drawdown −29.4%From 1-month high −29.4%3 months +57.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$63.2M
Quote Oct 16
Next earnings
Nov 12
Expected, not confirmed
Analyst target
$9.00
+696.5% from here
Floor
$1.03
9.0% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about PDSBPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
21
Founded
2005